3 Triple Negative Breast Cancer Clinical Trials in Phoenix, AZ (2026)

Q: How do I join a clinical trial in Phoenix?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you.

Recruiting Triple Negative Breast Cancer Studies in Phoenix

NCT05633654Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatmen...

Phoenix, AZPHASE31,514 participantsGilead Sciences

View Study Details

NCT05377996Recruiting

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

A Study of Emi-Le in Participants with Solid Tumors...

Phoenix, AZPHASE1360 participantsDay One Biopharmaceuticals, Inc.

View Study Details

NCT06349642Recruiting

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

This study is being done to collect tissue samples to test how accurately a tumor response platform, Elephas, can predict clinical response across multiple types of immunotherapies, chemoimmunotherapy...

Phoenix, AZ324 participantsMayo Clinic

View Study Details

About Triple Negative Breast Cancer Clinical Trials in Phoenix

Triple-negative breast cancer (TNBC) lacks estrogen receptors, progesterone receptors, and excess HER2 protein, limiting targeted treatment options. It accounts for about 10-15% of breast cancers and tends to be more aggressive. Active research focuses on immunotherapy and novel drug combinations.

There are currently 3 triple negative breast cancer clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 2,198 participants. Research is being sponsored by Gilead Sciences, Day One Biopharmaceuticals, Inc., Mayo Clinic. Clinical trial participation is free and participants receive study-related medical care at no cost.

Triple Negative Breast Cancer Clinical Trials in Phoenix — FAQ

Are there triple negative breast cancer clinical trials in Phoenix?

Yes, there are 3 triple negative breast cancer clinical trials currently recruiting in Phoenix, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Phoenix?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you about next steps.

Are clinical trials in Phoenix free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phoenix studies also compensate for your time and travel.

What triple negative breast cancer treatments are being tested?

The 3 active trials in Phoenix are testing new therapies including novel drugs, biologics, and treatment approaches for triple negative breast cancer.

Data updated October 19, 2026 from ClinicalTrials.gov